Total Payments
$1,804
2022 Payments
$137.91
Companies
13
Transactions
28
Payment Breakdown by Category
Food & Beverage$1,804 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,804 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $395.91 | 6 | $0 (2022) |
| Coherus Biosciences Inc. | $342.53 | 3 | $0 (2021) |
| Eisai Inc. | $220.75 | 2 | $0 (2021) |
| Incyte Corporation | $158.64 | 4 | $0 (2021) |
| TerSera Therapeutics LLC | $125.27 | 1 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $125.00 | 1 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $123.42 | 1 | $0 (2021) |
| Celgene Corporation | $88.04 | 1 | $0 (2021) |
| Ipsen Biopharmaceuticals, Inc | $87.68 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $86.74 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $137.91 | 3 | Novocure Inc. ($118.56) |
| 2021 | $1,494 | 21 | Coherus Biosciences Inc. ($342.53) |
| 2020 | $172.25 | 4 | Novocure Inc. ($130.25) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/01/2022 | Novocure Inc. | NovoTTF-100L (Device) | Food and Beverage | Cash or cash equivalent | $3.80 | General |
| Category: Oncology | ||||||
| 03/10/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA, WELIREG | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2022 | Novocure Inc. | NovoTTF-100L (Device) | Food and Beverage | Cash or cash equivalent | $114.76 | General |
| Category: Oncology | ||||||
| 12/16/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $119.70 | General |
| Category: Oncology | ||||||
| 12/02/2021 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $120.20 | General |
| Category: Oncology | ||||||
| 11/19/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL ONCOLOGY (Device) | Food and Beverage | In-kind items and services | $123.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/12/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2021 | Incyte Corporation | JAKAFI (Drug), PEMAZYRE, MONJUVI | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: Hematology/Oncology | ||||||
| 10/07/2021 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $96.19 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 08/05/2021 | Ipsen Biopharmaceuticals, Inc | ONIVYDE (Drug) | Food and Beverage | In-kind items and services | $87.68 | General |
| Category: Oncology | ||||||
| 07/28/2021 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $88.04 | General |
| 07/27/2021 | TerSera Therapeutics LLC | Xermelo (Drug) | Food and Beverage | In-kind items and services | $125.27 | General |
| Category: Oncology | ||||||
| 07/22/2021 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $12.66 | General |
| Category: Oncology | ||||||
| 07/15/2021 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 07/13/2021 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $122.76 | General |
| Category: Oncology | ||||||
| 07/02/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 06/24/2021 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Oncology | ||||||
| 06/17/2021 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $121.66 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 06/11/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Oncology | ||||||
| 06/04/2021 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| Category: Hematology/Oncology | ||||||
| 05/28/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2021 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $101.05 | General |
| Category: Oncology | ||||||
| 02/19/2021 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| 02/17/2021 | Coherus Biosciences Inc. | — | Food and Beverage | In-kind items and services | $124.68 | General |
| 11/12/2020 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $130.25 | General |
| Category: Optune | ||||||
About Dr. Abbas Rattani, MD
Dr. Abbas Rattani, MD is a Radiation Oncology healthcare provider based in Exeter, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2019. The National Provider Identifier (NPI) number assigned to this provider is 1700346368.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abbas Rattani, MD has received a total of $1,804 in payments from pharmaceutical and medical device companies, with $137.91 received in 2022. These payments were reported across 28 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,804).
Ad
Practice Information
- Specialty Radiation Oncology
- Location Exeter, NH
- Active Since 03/20/2019
- Last Updated 09/23/2024
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1700346368
Products in Payments
- Lenvima (Drug) $220.75
- Udenyca (Biological) $217.85
- Optune (Device) $147.10
- Oncology (Device) $130.25
- Xermelo (Drug) $125.27
- Vitrakvi (Drug) $125.00
- GENERAL ONCOLOGY (Device) $123.42
- MONJUVI (Drug) $122.76
- NovoTTF-100L (Device) $118.56
- ONIVYDE (Drug) $87.68
- KEYTRUDA (Biological) $86.74
- JAKAFI (Drug) $35.88
- Nplate (Biological) $15.50
- LIBTAYO (Biological) $12.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.